comparemela.com

Latest Breaking News On - Advisory board of viewray inc - Page 1 : comparemela.com

ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy

/PRNewswire/ ViewRay, Inc. (NASDAQ: VRAY) today announced the launch of a phase III randomized controlled trial titled "Locally Advanced Pancreatic cancer.

United statesMichaeld chuongMichael chuongJulie fleshmanAdvisory board of viewray incPrnewswire viewray incViewray incBaptist health south floridaMiami cancer institutePancreatic cancer action network panAdvanced pancreaticMedical directorRadiation oncologyBaptist health southMartin fussChief medical officer

New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting

/PRNewswire/ ViewRay, Inc. (NASDAQ: VRAY) today announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with.

United statesMichael chuongJulie fleshmanAdvisory board of viewray incPrnewswire viewray incAcibadem healthcare groupBaptist health south floridaPancreatic cancer action network panExchange commissionMiami cancer instituteViewray incHenry ford medical centerAnnual meetingAmerican societyRadiation oncologyTerm multi institutional outcomes

vimarsana © 2020. All Rights Reserved.